人工胰腺精确控制策略的最新进展
Wuyi Ming1, Xudong Guo1, Guojun Zhang2
1Henan Key Lab of Intelligent Manufacturing of Mechanical Equipment, Zhengzhou University of Light Industry, 450002, Zhengzhou, China.
Medical & biological engineering & computing
|February 28, 2024
概括
开发人工胰腺需要克服闭环血糖控制方面的挑战. 本综述分析了人工胰腺系统的控制算法和未来方向,以改善糖尿病管理.
科学领域:
- 生物医学工程 生物医学工程
- 控制系统 控制系统
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病的管理需要频繁的血糖检测和胰岛素供应用于正常血糖.
- 具有连续血糖监测的人工胰腺是一个关键的医学研究目标.
- 血糖的闭环控制与时间延迟在人工胰腺发育中构成了重大挑战.
研究的目的:
- 审查人工胰腺系统的组成,结构和控制特征.
- 分析各种控制算法对人工胰腺应用的研究进展和适用性.
- 突出人工胰腺技术的关键进展和未来研究方向.
主要方法:
- 介绍人工胰腺系统的组件和控制原理.
- 对比例-积分-差分,模型预测和人工智能控制算法的审查和比较分析.
- 检查血糖监测,自适应模型,可穿戴设备和自动化系统方面的进展.
主要成果:
- 对不同的控制策略进行比较,评估它们在人工胰腺使用方面的优缺点.
- 确定持续血糖监测和系统自动化的关键技术进步.
- 讨论当前控制算法的适用于实际人工胰腺实施的适用性.
结论:
- 未来的研究应该专注于饮食预测,控制安全,系统集成和算法优化.
- 需要进一步开发胰岛素温度保护和双激素人工胰腺系统.
- 解决这些挑战对于人工胰腺技术的成功临床应用至关重要.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
01:24Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
01:29Chronic Pancreatitis II: Collaborative Care
88
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
88